HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.

Abstract
Lafora's disease (LD) is an autosomal recessive and fatal form of epilepsy with onset in late childhood or adolescence. One of the characteristic features of LD pathology is the presence of periodic acid-Schiff (PAS) positive Lafora inclusion bodies. Lafora bodies are present primarily in neurons, but they have also been found in other organs. Histochemical and biochemical studies have indicated that Lafora bodies are composed mainly of polysaccharides. The LD gene, EPM2A, encodes a 331 amino acid long protein named laforin that contains an N-terminal carbohydrate-binding domain (CBD) and a C-terminal dual-specificity phosphatase domain (DSPD). Here we demonstrate that the CBD of laforin targets the protein to Lafora inclusion bodies and this property could be evolutionarily conserved. We also tested in vitro the effects of five LD missense mutations on laforin's affinity to Lafora body. While the missense mutant W32G failed to bind to purified Lafora body, four other mutants (S25P, E28L, F88L, and R108C) did not show any effect on the binding affinity. Based on these observations we propose the existence of a laforin-mediated glycogen metabolic pathway regulating the disposal of pathogenic polyglucosan inclusions. This is the first report demonstrating a direct association between the LD gene product and the disease-defining storage product, the Lafora bodies.
AuthorsSubramaniam Ganesh, Naomi Tsurutani, Toshimitsu Suzuki, Yoshinobu Hoshii, Tokuhiro Ishihara, Antonio V Delgado-Escueta, Kazuhiro Yamakawa
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 313 Issue 4 Pg. 1101-9 (Jan 23 2004) ISSN: 0006-291X [Print] United States
PMID14706656 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucans
  • Recombinant Fusion Proteins
  • polyglucosan
  • Dual-Specificity Phosphatases
  • Epm2a protein, mouse
  • Protein Tyrosine Phosphatases
  • Protein Tyrosine Phosphatases, Non-Receptor
  • EPM2A protein, human
Topics
  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Carbohydrate Metabolism
  • Chickens
  • Conserved Sequence
  • Dual-Specificity Phosphatases
  • Glucans (metabolism)
  • Humans
  • In Vitro Techniques
  • Inclusion Bodies (metabolism, pathology)
  • Lafora Disease (genetics, metabolism, pathology)
  • Mice
  • Mice, Knockout
  • Molecular Sequence Data
  • Mutation
  • Protein Structure, Tertiary
  • Protein Tyrosine Phosphatases (chemistry, genetics, metabolism)
  • Protein Tyrosine Phosphatases, Non-Receptor
  • Recombinant Fusion Proteins (chemistry, genetics, metabolism)
  • Sequence Homology, Amino Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: